A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer
There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads
Read MoreThere is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads
Read More